Soluble selectin levels in patients with lung cancer

International Journal of Biological Markers

Volumn 17, Issue 1, 2002, Pages 56-62

  Roselli, M ^a   Mineo, T C ^a   Martini, F ^a   Mariotti, S ^a   Ambrogi, V ^a   Spila, A ^a   D'Alessandro, R ^a   Basili, S ^a   Guadagni, F ^a   Ferroni, Patrizia ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

E selectin; Lung cancer; Metastasis; P selectin; Soluble adhesion molecule

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; PADGEM PROTEIN; SELECTIN;

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; BENIGN TUMOR; CANCER PATIENT; CANCER STAGING; CAPILLARY; CHEMOTAXIS; COMPARATIVE STUDY; CONTROLLED STUDY; DONOR; ENDOTHELIUM CELL; FEMALE; HUMAN; LABORATORY TEST; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; PATHOLOGY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REGRESSION ANALYSIS; STROMA; TUMOR CELL; VENULE;

EID: 10744219554     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2008.911     Document Type: Article

References (44)

1. Selectin ligands
2. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco) lipid metabolism
3. Interleukin-1 promotes tumor cell adhesion to cultured human endothelial cells
4. An inducible endothelial cell surface glycoprotein mediates melanoma adhesion
5. Platelets and cancer metastasis: More than an epiphenomenon
6. P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer
7. P-selectin-mediated attachment of small cell lung carcinoma to endothelial cells
8. The CD24/P-selectin binding pathway initiates lung arrest of human A125 adenocarcinoma cells
9. Enhanced expression of alpha(1,3)-fucosyltransferase genes correlates with E-selectin-mediated adhesion and metastatic potential of human lung adenocarcinoma cells
10. Expression of E-selectin, intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1 in non-small cell lung carcinoma
11. Circulating adhesion molecules in disease
12. Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies
13. Elevated serum E-selectin in patients with liver metastases of colorectal cancer
14. Serum concentrations of soluble adhesion molecules in patients with colorectal cancer
15. Relationship between serum ELAM-1 and metastasis among patients with colon cancer
16. Serum levels of the soluble adhesion molecules in patients with malignant melanoma
17. Increased soluble P-selectin in patients with haematological and breast cancer: A comparison with fibrinogen, plasminogen activator inhibitor and von Willebrand factor
18. Relation between the serum E-selectin level and the survival rate of patients with resected non-small cell lung cancers
19. Circulating intercellular adhesion molecule-1 and E-selectin levels in gastric cancer
20. The relationship between concentrations of circulating soluble E-selectin and clinical, pathological, and biological features in patients with breast cancer
21. Serum levels of soluble intercellular adhesion molecule-1 and E-selectin in metastatic breast carcinoma: Correlations with clinicopathological features and prognosis
22. Significance of soluble endothelial molecule E-selectin in patients with breast cancer
23. Angiogenesis is mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1
24. Novel synthetic analogs of sialyl Lewis X can inhibit angiogenesis in vitro and in vivo
25. Cell adhesion and angiogenesis
26. Leukocyte interactions mediated by selectins
27. Properties of GMP-140, an inducible granule membrane protein of platelets and endothelium
28. Characterization of GMP-140 (P-selectin) as a circulating plasma protein
29. In vivo tracking of platelets: Circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function
30. P-selectin and platelet clearance
31. Molecular insights into the anticoagulant-induced spontaneous activation of platelets in whole blood - Various anticoagulants are not equal
32. Validation of blood collection procedures for the determination of circulating vascular endothelial growth factor (VEGF) in different blood compartments
33. Hypothesis: Is soluble P-selectin a new marker of platelet activation?
34. Abnormalities of hemostasis in malignancy
35. Soluble P-selectin as a marker of platelet hyperactivity in patients with chronic obstructive pulmonary disease
36. In vivo thrombin generation and platelet hyperactivity in patients with chronic obstructive pulmonary disease
37. Rebuttal to circulating IL-6 levels in chronic obstructive pulmonary disease
38. Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo
39. Role of the coagulation system in tumor cell-induced platelet aggregation and metastasis
40. Platelet-aggregating activities of metastasizing tumor cells. III. Platelet aggregation as resulting from thrombin generation by tumor cells
41. Coagulation-fibrinolysis system and markers of collagen metabolism in lung cancer
42. Evaluating prethrombotic state in lung cancer using molecular markers
43. Haemostatic abnormalities in lung cancer: Prognostic implications
44. Activation of coagulation and angiogenesis in cancer: Immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer